Chemoinformaics analysis of 11,13-dihydrotaraxin acid-beta-d-glucopyranosyl-ester
Molecular Weight | 426.462 | nRot | 3 |
Heavy Atom Molecular Weight | 396.222 | nRig | 22 |
Exact Molecular Weight | 426.189 | nRing | 3 |
Solubility: LogS | -2.528 | nHRing | 2 |
Solubility: LogP | 0.96 | No. of Aliphatic Rings | 3 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
Atoms Count | 60 | No. of Aliphatic Hetero Cycles | 2 |
No. of Heavy Atom | 30 | No. of Aromatic Carbocycles | 0 |
nHetero | 9 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 30 | No. of Saturated Hetero Cycles | 2 |
No. of Carbon atom | 21 | No. of Saturated Rings | 2 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 9 | No. of Arom Bond | 0 |
nHA | 9 | APOL | 62.2918 |
nHD | 4 | BPOL | 37.0402 |
QED | 0.361 |
Synth | 5.169 |
Natural Product Likeliness | 2.916 |
NR-PPAR-gamma | 0.012 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Rejected |
Golden Triangle | Accepted |
Pgp-inh | 0.15 |
Pgp-sub | 0.866 |
HIA | 0.986 |
CACO-2 | -5.374 |
MDCK | 0.000111203 |
BBB | 0.153 |
PPB | 0.744207 |
VDSS | 1.282 |
FU | 0.188992 |
CYP1A2-inh | 0.062 |
CYP1A2-sub | 0.067 |
CYP2c19-inh | 0.024 |
CYP2c19-sub | 0.27 |
CYP2c9-inh | 0.013 |
CYP2c9-sub | 0.331 |
CYP2d6-inh | 0.006 |
CYP2d6-sub | 0.104 |
CYP3a4-inh | 0.242 |
CYP3a4-sub | 0.137 |
CL | 4.181 |
T12 | 0.711 |
hERG | 0.042 |
Ames | 0.102 |
ROA | 0.207 |
SkinSen | 0.315 |
Carcinogencity | 0.045 |
EI | 0.011 |
Respiratory | 0.261 |
NR-Aromatase | 0.349 |
Antiviral | Yes |
Prediction | 0.593303 |